- Product Name
- Product Keyword
- Product Model
- Product Summary
- Product Description
- Multi Field Search
introduction
Supplementing with ALA has been shown to offer a wide range of benefits. For example, it has been found to improve glucose uptake in the body, which makes it a useful supplement for those with type 2 diabetes. Additionally, ALA has been shown to reduce inflammation, improve brain function, and provide anti-aging effects.
One of the key benefits of ALA is its ability to protect against oxidative stress. This occurs when there is an imbalance of free radicals and antioxidants in the body. Free radicals are unstable molecules that can damage cells and contribute to the development of chronic diseases. ALA helps to neutralize these free radicals and can protect against oxidative damage.
ALAs effectiveness as an antioxidant has also led to its use in skincare products. It has been found to help reduce the appearance of fine lines and wrinkles, as well as improve overall skin texture and tone.
In conclusion, alpha lipoic acid is a versatile and valuable nutrient that can benefit the body in many ways. Whether you're looking to improve your overall health or simply enhance your skincare routine, ALA is a supplement worth considering. So why not give it a try and see what benefits it can provide for you?
| Product Information | |
| Number | |
| Name | Alpha lipoic acid |
| Specification | 99%~101% |
| Efficacy | |
| CAS No. | 62-46-4;1077-28-7 |
| Constitutional Formula | C8H14O2S2 |
| introduction | Appearance yellowish-green crystal powder Conforms Organoleptic Identification Observe the conditions Conforms HPLC melting point 61.8 °C at 60–62 °C USP |
| Indications and Uses | 1. antioxidant. 2. Assisting patients in lessening reliance on oral glucose-lowering medications and insulin. 3. Preserving the nerve tissue of diabetes patients and aiding in the treatment of peripheral neuropathy. 4. When combined with vitamins, this medication aids in the treatment of diabetes, fatty liver disease, cirrhosis, acute and chronic hepatitis, and hepatic coma. |
| The Information had not been evaluated by the Food and Drug Administration, only for reference | |
